Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma

Malignant mesothelioma is an aggressive cancer with limited treatment options and poor prognosis. A better understanding of mesothelioma genomics and transcriptomics could advance therapies. Here, we present a mesothelioma cohort of 122 patients along with their germline and tumor whole-exome and tu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Nishanth Ulhas, Jiang, Qun, Wei, Jun Stephen, Misra, Vikram Alexander, Morrow, Betsy, Kesserwan, Chimene, Hermida, Leandro C., Lee, Joo Sang, Mian, Idrees, Zhang, Jingli, Lebensohn, Alexandra, Miettinen, Markku, Sengupta, Manjistha, Khan, Javed, Ruppin, Eytan, Hassan, Raffit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975319/
https://www.ncbi.nlm.nih.gov/pubmed/36773602
http://dx.doi.org/10.1016/j.xcrm.2023.100938

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975319/
https://www.ncbi.nlm.nih.gov/pubmed/36773602
http://dx.doi.org/10.1016/j.xcrm.2023.100938

Ejemplares similares